|
Chairman and Chief Executive Officer
Nutra Pharma Corporation
Rik J. Deitsch has been the President,
Chief Executive Officer and a Director of
the Company since November 7, 2002. From
February 1998 through November 2002, Mr.
Deitsch served as the President of NDA Consulting
Inc., a biotechnology research group that
provided consulting services to the pharmaceutical
industry. NDA Consulting specialized in
the research of peptides derived from Cone
Snail venom, Cobra venom and Gila Monster
venom. Mr. Deitsch holds both a B.S. in
Chemistry and an M.S. in Biochemistry from
Florida Atlantic University and has conducted
clinical and laboratory research in collaboration
with scientists at Duke University Medical
Center and the Cleveland Clinic . Mr. Deitsch
is an adjunct professor and teaches several
courses for Florida Atlantic University's
College of Business and Continuing Education
Department. |
| |
|
| |
|
|
Chief Executive Officer
ReceptoPharm, Inc.
Paul F. Reid, Ph.D., is a Co-Founder and
Chief Executive Officer of ReceptoPharm.
Dr. Reid is equipped with a broad scientific
background, encompassing 14+ years in clinical
development and research, with a direct
approach to moving products from preclinical
into clinical phases. He has worked and
negotiated with drug regulatory agencies
in the US, Canada, EU, South America, South
Africa, and China, enabling companies to
move ahead, save millions on research and
testing in clinical trials, and gain IND
approvals. By leveraging his comprehensive
understanding of regulatory requirements
he can guide new projects through the correct
protocols at a minimum budget, advancing
products, positioning for licensing, and
setting up manufacturing. The application
of his knowledge of laboratory practices
to select new technologies that enhance
production, quality control, and product
formats. Dr. Reid is a leading world expert
in the therapeutic use of snake venom neurotoxins.
|
| |
|
| |
|
|
President
Designer Diagnostics, Inc.
Neil Roth joined Nutra Pharma
Corporation in 2005 as President of Designer
Diagnostics, Inc. He has over 30 years experience
in the sales and marketing of consumer goods
including pharmaceuticals and medical devices.
His prior experience included senior management
and top marketing positions of major multibillion-dollar
companies, including: Revco, Eckerd Drugs
and Thrifty Drugs. He has successfully increased
sales in the companies that he has been
associated with through his expertise and
understanding of the creation of marketing
plans into new and developing markets. |
|
|
| |
|
|
|
| |
|
| Click
Here for an Update on the Phase IIb Clinical Trial
Data. |
|
|
|
|
| |
|